The WNK1/OSR1 protein pathway's role in brain insulin use and age-related memory loss

WNK1/OSR1 axis in Hippocampal Insulin Signaling, Glucose Metabolism and Age-related Cognitive Dysfunction

NIH-funded research University of North Texas Hlth Sci Ctr · NIH-11479058

This project will see if the WNK1/OSR1 protein pathway makes the aging brain use insulin and sugar less well and whether fixing that can help memory in Alzheimer’s-related conditions.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of North Texas Hlth Sci Ctr NIH-funded
Lab location1 site (Fort Worth, United States)
Project IDNIH-11479058 on NIH RePORTER

What this research studies

From a patient perspective, researchers will use lab experiments and mouse models of Alzheimer’s to study how the WNK1/OSR1 proteins affect insulin signaling and glucose uptake in the hippocampus, a brain area important for memory. They will look at molecular steps such as AKT signaling and GLUT4 trafficking, manipulate WNK1/OSR1 activity, and measure effects on glucose use by neurons. The team will also test whether these changes relate to memory performance in the mice. Results are meant to reveal mechanisms linking brain insulin resistance to age-related cognitive decline and point toward targets for future therapies.

Who could benefit from this research

Good fit: People with early-stage Alzheimer’s disease, mild cognitive impairment, or age-related memory decline would be the likely candidates for any future clinical trials based on this work.

Not a fit: Individuals with very advanced dementia or memory loss caused primarily by stroke, brain injury, or non-Alzheimer’s conditions may not benefit from findings focused on hippocampal insulin signaling.

Why it matters

Potential benefit: If successful, the work could point to new targets to improve brain insulin use and protect memory in people with age-related cognitive decline or Alzheimer’s disease.

How similar studies have performed: Prior studies link brain insulin resistance to Alzheimer’s, but targeting the WNK1/OSR1 pathway and its effect on neuronal GLUT4 trafficking is a newer and largely untested approach.

Where this research is happening

Fort Worth, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.